| Patient | Sir John Franklin |
|---|---|
| Date of birth | 1786-04-16 |
| Identifiers | MRN HR-EX005-SYN-TD; SSN (made up) 000-05-3328 |
| Document date | 2026-11-01 |
| Author | Cordelia Ashby-Nwankwo, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Pre-expedition medical for a 58-year-old naval officer chosen to command a multi-year Arctic expedition: history, examination, ECG, laboratory tests, hearing, mood, a high blood pressure reading, and a wilderness and expedition medicine consultation. Concerns: He wants to be found fit for the command, and to be fit enough to do it well; Staying well, and keeping his men well, for years beyond the reach of a doctor's office or hospital; He remembers what starvation did on an earlier journey and wants a food plan that will not fail. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg oral tablet once daily | One tablet by mouth every morning | Oral route | 1845-01-27 | active | S |
| Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once daily, continued through the polar winters | One tablet by mouth daily | Oral route | 1845-01-27 | active | S |
| Vitamin C (ascorbic acid) 250 mg oral tablet once daily for the whole expedition, stored sealed and away from heat and light, in addition to food sources | One tablet by mouth daily from departure | Oral route | 1845-05-05 | active | S |
| Oseltamivir 75 mg oral capsule twice daily for five days | One capsule by mouth twice a day for five days | Oral route | 1845-02-10 to 1845-02-14 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Resting 12-lead ECG: sinus rhythm at 76, normal axis and intervals, no left ventricular hypertrophy by voltage criteria, no Q waves | 1845-01-13 to 1845-01-13 | completed | S |
| Pure tone audiometry: symmetric high-frequency sensorineural loss with a notch at 4 kHz (45 dB) on both sides; speech frequencies within 25 dB; normal tympanograms | 1845-01-13 to 1845-01-13 | completed | S |
| Transthoracic echocardiogram: left ventricular ejection fraction 62%, mild concentric remodeling (septum 11 mm), normal diastolic function for age, normal valves and aortic root | 1845-02-24 to 1845-02-24 | completed | S |
| Symptom-limited exercise treadmill test (Bruce protocol): 9 minutes, about 10 METs, peak heart rate 152 (94% of predicted), normal blood pressure response, no chest pain, arrhythmia or ischemic ST change | 1845-04-07 to 1845-04-07 | completed | S |
| Advance care planning conversation, about 25 minutes, including his wishes for serious illness at sea or in the ice beyond the reach of evacuation | 1845-03-10 to 1845-03-10 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 1845-03-10 | Tetanus, diphtheria and acellular pertussis (Tdap) booster | completed | S |
| 1845-03-10 | Pneumococcal conjugate vaccine (PCV20), single dose | completed | S |
| 1845-03-10 | Recombinant zoster vaccine, first of two doses | completed | S |
| 1845-03-10 | Hepatitis B vaccine (HepB-CpG), first of two doses | completed | S |
| 1845-03-10 | Rabies vaccine (human diploid cell), pre-exposure prophylaxis, first of two doses | completed | S |
| 1845-03-17 | Rabies vaccine (human diploid cell), pre-exposure prophylaxis, second of two doses, given by the clinic nurse | completed | S |
| 1845-04-07 | Hepatitis B vaccine (HepB-CpG), second of two doses | completed | S |
| 1845-05-05 | Recombinant zoster vaccine, second of two doses | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1801 to 1805 | Mild hearing loss from the noise of naval gunfire in his youth | D (CLM-0002) |
| December 14, 1814 | Slight wound in battle; healed | D (CLM-0003) |
| Autumn 1821 | Prolonged starvation and exposure on an Arctic land expedition, surviving on lichen and boiled leather; recovered | D (CLM-0004) |
No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.
| Concern | Status | Evidence |
|---|---|---|
| He wants to be found fit for the command, and to be fit enough to do it well | active | S |
| Staying well, and keeping his men well, for years beyond the reach of a doctor's office or hospital | active | S |
| He remembers what starvation did on an earlier journey and wants a food plan that will not fail | active | S |
Most recent measures: Sodium [Moles/volume] in Serum or Plasma 139 on 1845-05-05; Potassium [Moles/volume] in Serum or Plasma 4.3 on 1845-05-05; Creatinine [Mass/volume] in Serum or Plasma 0.96 on 1845-05-05; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1840)/1.73 sq M 90 on 1845-05-05; Glucose [Mass/volume] in Serum or Plasma 96 on 1845-01-13; Hemoglobin [Mass/volume] in Blood 15.1 on 1845-01-13; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 1845-01-13; Cholesterol [Mass/volume] in Serum or Plasma 188 on 1845-01-13; Cholesterol in HDL [Mass/volume] in Serum or Plasma 52 on 1845-01-13; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 112 on 1845-01-13; Triglyceride [Mass/volume] in Serum or Plasma 120 on 1845-01-13; Thyrotropin [Units/volume] in Serum or Plasma 1.9 on 1845-01-13; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 34 on 1845-01-13; Lead [Mass/volume] in Blood 1.8 on 1845-01-13; Ascorbate [Mass/volume] in Serum or Plasma 0.8 on 1845-01-13; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 1845-05-05; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 2 on 1845-05-05; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 on 1845-05-05; Total score [AUDIT-C] 3 on 1845-01-13; Albumin/Creatinine [Mass Ratio] in Urine 12 on 1845-02-24; Left ventricular Ejection fraction 62 on 1845-02-24; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1845-03-10 [S]
Strengths and supports: engagement in care [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| High blood pressure found at the pre-expedition medical (152/94 mmHg, average of two readings), without a prior diagnosis; home readings for one week ordered to confirm | resolved | confirmed | R03.0 | S — Synthetic presenting finding at a pre-expedition fitness assessment, anchored to the documented doubts about his fitness; superseded when home readings confirmed hypertension. |
| Essential hypertension, stage 2 by home readings (one-week average 144/90 mmHg), without target-organ damage; synthetic | active | confirmed | I10 | S — Synthetic modern diagnosis confirmed by home monitoring at the consultation; no blood pressure from his lifetime is recorded. |
| Obesity, class 1 (BMI 31.4 at intake), with a waist of 106 cm; he sets his own goals for activity and food | active | confirmed | E66.811 | S — Synthetic modern finding anchored to the documented description of his build as portly; no weight from his lifetime is recorded. |
| Medical preparation for a multi-year Arctic expedition beyond the reach of hospital care: fitness, cold injury, nutrition and food safety, vaccinations, dental care, mental health in isolation, a medical kit and an evacuation plan | active | confirmed | Z71.84 | S — Synthetic travel-health problem anchored to the documented expedition. |
| Bilateral high-frequency sensorineural hearing loss from noise, mild; trouble hearing in noisy rooms | active | confirmed | H83.3X3 | S — Synthetic modern coding of the documented mild hearing loss from naval gunfire; the audiogram is synthetic. |
| Vitamin D insufficiency in midwinter (25-hydroxyvitamin D 22 ng/mL), with years of polar darkness ahead | active | confirmed | E55.9 | S — Synthetic laboratory finding at intake. |
| Influenza A, confirmed by rapid molecular test, with fever, cough and aches, without pneumonia; treated with oseltamivir; recovered with a lingering cough | resolved | confirmed | J10.1 | S — Synthetic modern illness anchored to the documented severe influenza of the winter before the expedition; the test, course and treatment are synthetic. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1845-01-13 | Sodium [Moles/volume] in Serum or Plasma | 140 | mmol/L | 135-146 mmol/L | Normal | S |
| 1845-01-13 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 1845-01-13 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 1845-01-13 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1840)/1.73 sq M | 88 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1845-01-13 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 65-99 mg/dL | Normal | S |
| 1845-01-13 | Hemoglobin [Mass/volume] in Blood | 15.1 | g/dL | 13.2-17.1 g/dL | Normal | S |
| 1845-01-13 | Hemoglobin A1c/Hemoglobin.total in Blood | 5.6 | % | Below 5.7% normal; 5.7 to 6.4% prediabetes | Normal | S |
| 1845-01-13 | Cholesterol [Mass/volume] in Serum or Plasma | 188 | mg/dL | <=199 mg/dL | Normal | S |
| 1845-01-13 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 52 | mg/dL | >=40 mg/dL | Normal | S |
| 1845-01-13 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 112 | mg/dL | <=99 mg/dL | High | S |
| 1845-01-13 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | <=149 mg/dL | Normal | S |
| 1845-01-13 | Thyrotropin [Units/volume] in Serum or Plasma | 1.9 | m[IU]/L | 0.4-4.5 mIU/L | Normal | S |
| 1845-01-13 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 34 | U/L | 9-46 U/L | Normal | S |
| 1845-01-13 | Lead [Mass/volume] in Blood | 1.8 | ug/dL | Below 3.5 micrograms per deciliter | Normal | S |
| 1845-01-13 | Ascorbate [Mass/volume] in Serum or Plasma | 0.8 | mg/dL | Below 0.2 mg/dL is deficient | Normal | S |
| 1845-01-13 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 22 | ng/mL | Below 20 ng/mL deficient; 20 to 29 insufficient | Low | S |
| 1845-01-13 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 1845-01-13 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | {score} | S | ||
| 1845-01-13 | Total score [AUDIT-C] | 3 | {score} | S | ||
| 1845-02-24 | Albumin/Creatinine [Mass Ratio] in Urine | 12 | mg/g | Below 30 mg/g normal | Normal | S |
| 1845-02-24 | Left ventricular Ejection fraction | 62 | % | 52-72% | Normal | S |
| 1845-03-10 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 1845-05-05 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-146 mmol/L | Normal | S |
| 1845-05-05 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.3 mmol/L | Normal | S |
| 1845-05-05 | Creatinine [Mass/volume] in Serum or Plasma | 0.96 | mg/dL | 0.7-1.3 mg/dL | Normal | S |
| 1845-05-05 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1840)/1.73 sq M | 90 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1845-05-05 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 34 | ng/mL | Below 20 ng/mL deficient; 20 to 29 insufficient | Normal | S |
| 1845-05-05 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 2 | {score} | S | ||
| 1845-05-05 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 3 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1845-01-13 | Body height | 170 | cm | S |
| 1845-01-13 | Body weight | 90.8 | kg | S |
| 1845-01-13 | Body mass index (BMI) [Ratio] | 31.4 | kg/m2 | S |
| 1845-01-13 | Systolic blood pressure | 152 | mm[Hg] | S |
| 1845-01-13 | Diastolic blood pressure | 94 | mm[Hg] | S |
| 1845-01-13 | Heart rate | 78 | /min | S |
| 1845-01-13 | Respiratory rate | 14 | /min | S |
| 1845-01-13 | Body temperature | 36.6 | Cel | S |
| 1845-01-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1845-01-27 | Body height | 170 | cm | S |
| 1845-01-27 | Body weight | 90.4 | kg | S |
| 1845-01-27 | Body mass index (BMI) [Ratio] | 31.3 | kg/m2 | S |
| 1845-01-27 | Systolic blood pressure | 148 | mm[Hg] | S |
| 1845-01-27 | Diastolic blood pressure | 92 | mm[Hg] | S |
| 1845-01-27 | Heart rate | 76 | /min | S |
| 1845-01-27 | Respiratory rate | 14 | /min | S |
| 1845-01-27 | Body temperature | 36.6 | Cel | S |
| 1845-01-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1845-02-24 | Body height | 170 | cm | S |
| 1845-02-24 | Body weight | 89 | kg | S |
| 1845-02-24 | Body mass index (BMI) [Ratio] | 30.8 | kg/m2 | S |
| 1845-02-24 | Systolic blood pressure | 136 | mm[Hg] | S |
| 1845-02-24 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 1845-02-24 | Heart rate | 80 | /min | S |
| 1845-02-24 | Respiratory rate | 16 | /min | S |
| 1845-02-24 | Body temperature | 36.7 | Cel | S |
| 1845-02-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 1845-04-07 | Body height | 170 | cm | S |
| 1845-04-07 | Body weight | 87.6 | kg | S |
| 1845-04-07 | Body mass index (BMI) [Ratio] | 30.3 | kg/m2 | S |
| 1845-04-07 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1845-04-07 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1845-04-07 | Heart rate | 70 | /min | S |
| 1845-04-07 | Respiratory rate | 14 | /min | S |
| 1845-04-07 | Body temperature | 36.6 | Cel | S |
| 1845-04-07 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1845-05-05 | Body height | 170 | cm | S |
| 1845-05-05 | Body weight | 86.9 | kg | S |
| 1845-05-05 | Body mass index (BMI) [Ratio] | 30.1 | kg/m2 | S |
| 1845-05-05 | Systolic blood pressure | 126 | mm[Hg] | S |
| 1845-05-05 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1845-05-05 | Heart rate | 68 | /min | S |
| 1845-05-05 | Respiratory rate | 14 | /min | S |
| 1845-05-05 | Body temperature | 36.6 | Cel | S |
| 1845-05-05 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1845-03-10 | Body height | 170 | cm | S |
| 1845-03-10 | Body weight | 88.4 | kg | S |
| 1845-03-10 | Body mass index (BMI) [Ratio] | 30.6 | kg/m2 | S |
| 1845-03-10 | Systolic blood pressure | 132 | mm[Hg] | S |
| 1845-03-10 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 1845-03-10 | Heart rate | 72 | /min | S |
| 1845-03-10 | Respiratory rate | 14 | /min | S |
| 1845-03-10 | Body temperature | 36.6 | Cel | S |
| 1845-03-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| 1845-02-10 | Body height | 170 | cm | S |
| 1845-02-10 | Body weight | 89.6 | kg | S |
| 1845-02-10 | Body mass index (BMI) [Ratio] | 31 | kg/m2 | S |
| 1845-02-10 | Systolic blood pressure | 136 | mm[Hg] | S |
| 1845-02-10 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 1845-02-10 | Heart rate | 96 | /min | S |
| 1845-02-10 | Respiratory rate | 18 | /min | S |
| 1845-02-10 | Body temperature | 38.4 | Cel | S |
| 1845-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 1845-01-13 | Pre-expedition medical for a 58-year-old naval officer chosen to command a multi-year Arctic expedition: history, examination, ECG, laboratory tests, hearing, mood, a high blood pressure reading, and a wilderness and expedition medicine consultation | finished | S |
| 1845-01-27 | Two-week review of home blood pressure readings, seen the same day by wilderness and expedition medicine: the diagnosis, treatment for years away from care, cardiac testing, nutrition, cold and evacuation | finished | S |
| 1845-02-24 | Four-week review after starting amlodipine: blood pressure, side effects, echocardiogram and urine albumin | finished | S |
| 1845-04-07 | Eight-week review: blood pressure at goal, weight, exercise treadmill test and expedition planning | finished | S |
| 1845-05-05 | Pre-departure review two weeks before sailing: blood pressure, medicines and supplies, mental health, vaccinations, the medical kit and the evacuation plan | finished | S |
| 1845-03-10 | Periodic adult preventive visit | finished | S |
| 1845-02-10 | Same-day sick visit for influenza | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Pre-expedition medical: history, examination, resting ECG, kidney function and electrolytes, HbA1c, lipid panel, urine albumin, TSH, ALT, blood count, and baseline blood lead, vitamin C and vitamin D; audiogram; tuberculosis blood test because of a past household contact | completed | GL-AHA-HTN-2025, GL-CMID-2026, GL-USPSTF-LTBI-2023 | S |
| Wilderness and expedition medicine consultation to advise on fitness for the command, treatment for years away from care, nutrition and food safety, cold injury, and evacuation | completed | GL-WMS-FROST-2024, GL-WMS-HYPO-2019 | S |
| Blood pressure: a validated upper-arm home monitor with a large cuff, two readings morning and evening for seven days, to confirm the diagnosis; less salt, less alcohol, more vegetables and daily walking from today | completed | GL-AHA-HTN-2025, GL-CMID-2026 | S |
| Treatment: amlodipine 5 mg daily, with a goal below 130/80 mmHg at home, home readings weekly on board, and a supply for three years in blister packs; no diuretic or renin-angiotensin blocker because of dehydration, cold diuresis and no laboratory access; statin not started by his choice after a risk discussion | completed | GL-AHA-HTN-2025, GL-CMID-2026, GL-USPSTF-STATIN-2022 | S |
| Heart before a strenuous remote posting: echocardiogram for stage 2 hypertension, and a symptom-limited exercise treadmill test once he has recovered from any acute illness | completed | GL-AHA-HTN-2025, GL-CMID-2026 | S |
| Weight: his own goals for walking, hill work, portions and alcohol, discussed without blame; no weight-loss medicine before departure | completed | GL-USPSTF-OBESITY-2018, GL-AHA-HTN-2025 | S |
| Nutrition and food safety for years without fresh food: vitamin C 250 mg daily in sealed, cool, dark storage, with food sources and a check of the expedition's stores; vitamin D3 daily; an energy-dense ration; canned food from suppliers without lead solder, inspected for bulging, leaking or damaged cans, which are discarded unopened; no home-canned food; a blood lead baseline | completed | GL-CDC-BOT-2021, GL-KOSNETT-PB-2007, GL-CMID-2026 | S |
| Cold: layered clothing with vapor control, dry socks and mitts, buddy checks of face, hands and feet, no tobacco or alcohol before cold exposure, rewarming of frostbite only when refreezing can be prevented, and hypothermia recognition and insulation in the field | completed | GL-WMS-FROST-2024, GL-WMS-HYPO-2019 | S |
| Vaccinations, dental examination and treatment, and colorectal and other screening at the preventive visit before departure | completed | GL-PREV-2026, GL-CDC-IMZ-2026 | S |
| Mind and isolation: baseline PHQ-9 and GAD-7, a routine of work, light, exercise and sleep through the polar night, a peer-support plan among the officers, and an evacuation plan with a medical kit, written instructions for the ship's surgeons, and a 12-month review of medicines | completed | GL-USPSTF-DEP-2023, GL-WMS-HYPO-2019 | S |
| Hearing: audiogram, hearing protection around guns and engines, and seating so that his better ear faces the speaker | completed | GL-CMID-2026 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Confirm or exclude hypertension with a week of home readings | 1845-01-27 | completed | Home average 144/90 mmHg: stage 2 hypertension confirmed | S |
| Blood pressure below 130/80 mmHg at home before departure | 1845-04-07 | completed | Home average 127/79 mmHg at eight weeks on amlodipine 5 mg with lifestyle change | S |
| Lose about 5 percent of body weight before sailing by his own plan of walking, hill work and smaller portions | 1845-05-05 | completed | 90.8 to 86.9 kg (4.3 percent); waist 106 to 101 cm; he counts it as met and plans to keep walking on board | S |
| Medical clearance for the command with a written expedition health plan, medical kit and evacuation plan | 1845-05-05 | completed | Cleared at the pre-departure visit with no cardiac limitation; plan, kit list and supplies in hand | S |